Match Document Document Title
US20120214769 Novel Antagonists of the Glucagon Receptor  
The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity....
US20120156139 ISOTOPICALLY LABELED NEUROCHEMICAL AGENTS AND USES THEROF FOR DIAGNOSING CONDITIONS AND DISORDERS  
The invention relates to a neurochemical agent comprising at least one isotopically labeled carbon atom directly bonded to at least one deuterium atom, uses thereof for the manufacture of a...
US20110218359 PREPARATION OF ETHYLENICALLY UNSATURATED CARBOXYLIC SALTS BY CARBOXYLATION OF ALKENES  
A process for preparing an alkali metal or alkaline earth metal salt of an α,β-ethylenically unsaturated carboxylic acid, wherein a) an alkene, carbon dioxide and a carboxylation catalyst are...
US20100298597 PURIFICATION OF 5-SULFOISOPHTHALIC ACID BY THE USE OF AN ACETIC ACID WASH ON A CRUDE CAKE  
A method for the purification of 5-sulfoisophthalic acid wherein via the application of an acetic acid wash while said crude cake of 5-sulfoisophthalic acid is filtered.
US20100130766 POLYMERIZATION INHIBITION METHOD  
The objective of the present invention is to provide a method for inhibiting polymerization of (meth)acrylic acid and the like. By the method, the generation of deposit in a pipe, which is...
US20150080601 ISOMERIZED ALPHA OLEFIN SULFONATE AND METHOD OF MAKING THE SAME  
The present invention is directed to an isomerized alpha olefin sulfonate and a method of making the same wherein the isomerized alpha olefin sulfonate is derived from sulfonating an isomerized...
US20110152571 ISOMERIZED ALPHA OLEFIN SULFONATE AND METHOD OF MAKING THE SAME  
The present invention is directed to an isomerized alpha olefin sulfonate and a method of making the same wherein the isomerized alpha olefin sulfonate is derived from sulfonating an isomerized...
US20120041228 PHARMACEUTICAL COMPOSITION FOR AMELIORATING AND/OR PREVENTING LEPTIN RESISTANCE, AND USE THEREOF  
The present invention provides a pharmaceutical composition for ameliorating and/or preventing leptin resistance. The pharmaceutical composition of the present invention contains flurbiprofen.
US20090118543 METHOD FOR PRODUCING TRIFLUOROMETHANESULFONIC ANHYDRIDE  
This method for producing trifluoromethanesulfonic anhydride reacting trifluoromethanesulfonic acid with phosphorus pentoxide to produce trifluoromethanesulfonic anhydride, wherein hardening of...
US20090118538 PROCESS FOR PREPARATION OF PURE ACITRETIN  
Processes and systems for the preparation of substantially pure acitretin based on reacting crude acitretin and an amine in presence of a suitable solvent to provide a salt that is then reacted...
US20070213336 Biaromatic compound activators of ppargamma receptors and cosmetic/pharmaceutical compositions comprised thereof  
Novel biaromatic compounds having the general formula (I): and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the...
US20150197489 METHOD FOR THE PRODUCTION OF D,L-METHIONINE  
A method to produce D,L-Methionine from 2-hydroxy-4-(methylthio)butyronitrile by reaction with ammonia, optionally in the presence of carbon dioxide, is provided. The...
US20130189571 ORGANIC ACTIVE MATERIALS FOR BATTERIES  
A rechargeable battery includes a compound having at least two active sites, R1 and R2; wherein the at least two active sites are interconnected by one or more conjugated moieties; each active...
US20120123158 Method for Increasing Methionine Productivity Using a Mixture of Methyl Mercaptan and Dimethyl Sulfide  
The present invention relates to a method for increasing L-methionine productivity and organic acid productivity. More particularly, the present invention relates to a method which involves adding...
US20140024800 CARBON DIOXIDE CAPTURE AND CONVERSION TO A CARBAMATE SALT AND POLYUREA  
A method for treating carbon dioxide includes preparing a polyamine composition and delivering a stream containing carbon dioxide to the polyamine composition. The carbon dioxide reacts with...
US20060116531 Modeling of liquid-phase oxidation  
Disclosed is an optimized process for more effectively and efficiently modeling liquid-phase oxidation in a bubble column reactor.
US20110105788 Polymorphic Form of an Aminoindan Mesylate Derivative  
The invention relates to a polymorphic form of rasagiline mesylate, and to processes for preparing the same.
US20150056452 PULVERULENT COMPOSITIONS OF A COMPLEX BETWEEN AN ACID AND A METAL AND METHOD OF PREPARATION THEREOF  
The present invention relates to pulverulent compositions of a complex between an acid and a metal and the method of preparation thereof.
US20110131029 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAC-PB1N COMPLEX AND USES THEREOF  
Provided are the expression method of influenza virus polymerase PAc-PB1N complex, the co-crystallization method of the complex and the three-dimendional structure of the crystal of PAc-PB1N...
US20150105571 METHOD FOR CONVERTING CARBON DIOXIDE AND BICARBONATES INTO FORMIC ACID DERIVATIVES USING A COBALT COMPLEX AS A CATALYTIC SYSTEM  
The invention relates to a method for converting carbon dioxide or bicarbonates into formic acid derivatives, i.e. formate salts, formate esters, and formamides, using molecular hydrogen and a...
US20100010238 PROCESS FOR PRODUCING A RINGLIKE OXIDIC SHAPED BODY  
A process for producing a ringlike oxidic shaped body by mechanically compacting a pulverulent aggregate introduced into the fill chamber of a die, wherein the outer face of the resulting compact...
US20130068069 METALLURGICAL LUBRICANT POWDER AND METAL POWDER COMPOSITION  
A powder metallurgy lubricant includes an aromatic carboxylic acid represented by a formula (1), (Z)n-Ar—COOH (1) where Ar represents an aryl group and Z represents a substituent directly bonded...
US20080214866 Distillation Process  
A mixture containing hydrogen iodide and water and having a water content of not more than 5% by weight (particularly not more than 3% by weight) in a distillation system is distilled to prevent...
US20060235242 Recovering method of acetic acid from effluent of terephthalic acid production process  
The present invention relates to a recovering method of acetic acid using an apparatus comprising a dehydration tower, a condenser and a separation tank. As p-xylene is used as an azeotropic agent...
US20130228332 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, PREPARATION THEREOF AND USE THEREOF FOR MINERAL OIL PRODUCTION  
Novel derivatives of tris(2-hydroxyphenyl)methanes which have, as functional groups, polyalkoxy groups unmodified or modified with terminal hydrophilic groups, preparation of such compounds and...
US20120277264 ANTITHROMBOTIC AGENT  
An object of the present invention is to provide an antithrombotic agent that has fewer side effects and that is highly effective. The present invention provides an antithrombotic agent comprising...
US20060116427 Adapalene polymorphic forms  
Novel adapalene crystalline and amorphous Forms, processes for the preparation thereof, their use for the purification of adapalene, pharmaceutical compositions containing the forms and the use...
US20130023463 HIV PROTEASE INHIBITING COMPOUNDS  
A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
US20150174113 SUBSTITUTED AMINOINDANE- AND AMINOTETRALINECARBOXYLIC ACIDS AND THE USE THEREOF  
The present application relates to novel substituted aminoindane- and aminotetralinecarboxylic acids, to processes for preparation thereof, to the use thereof for treatment and/or prevention of...
US20150232405 METHOD FOR THE PRODUCTION OF NOBLE METAL OXALATE COMPLEXES  
The production of noble metal oxalate complexes from noble metal precursors and oxalic acid and/or oxalic acid salts is an exothermic reaction, in which heat and CO2 are produced, is described....
US20110108763 CATALYST SYSTEMS FOR THE PRODUCTION OF ACIDS  
Various embodiments of the invention herein described generally relate to novel processes for the production of aromatic acids by fixed bed catalytic oxidation of aromatic compounds carrying at...
US20090187019 Process for preparing diisopropyl((1-(hydroxymethyl)-cyclopropyl)oxy)methylphosphonate  
The present invention relates to a new process for preparing diisopropyl {[1-(hydroxymethyl)-cyclopropyl]oxy}methylphosphonate (2), which is a key intermediate for synthesizing an antiviral...
US20130217652 SULFINYLBENZYL AND THIOBENZYL DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS  
The present invention relates to novel thiobenzyl and sulfinylbenzyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as...
US20130217651 PHENOXY DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS  
The present invention relates to novel phenoxy derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of...
US20080242816 Neutralization Process  
The invention relates to a neutralization process in which at least one ethylenically unsaturated carboxylic acid is neutralized at least partly with a base and at least one stream of the...
US20060069038 Irreversible caspase-3 inhibitors as active site probes  
The present invention encompasses a compound of Formula (I) useful as caspase active site probes. These probes can be used to determine whether a caspase has been activated, in cells or in tissues...
US20140121403 Integrated Process for the Production of Acrylic Acids and Acrylates  
A process for producing an acrylate product from methanol and acetic acid, in which, in a reaction zone A, the methanol is partially oxidized to formaldehyde in a catalyzed gas phase reaction, the...
US20110269985 ISOTOPICALLY LABELED COMPOSITIONS AND METHOD  
Compounds having stable isotopes 13C and/or 2H were synthesized from precursor compositions having solid phase supports or affinity tags.
US20120129800 Agent For Preventing And Treating Pityriasis Versicolor  
The present invention concerns an agent for prevention and treatment of pityriasis. The agent according to the present invention comprises at least one transaminase inhibitor effectively...
US20120029230 METHOD FOR PREPARING CHIRAL BACLOFEN  
The present invention provides a novel method for preparing chiral Baclofen with higher yield, higher e.e. value, and lower cost via chiral Michael addition.
US20130330564 POLYMERIC CORROSION INHIBITER FOR METAL SURFACES AND THE PRODUCTION THEREOF  
The invention relates to a polymeric corrosion inhibiter for a metal substrate of formula (R1)aA(R2X)b, where a=0-3, b=1-6, A is a bridge structure unit, R1 is identical to or different from H or...
US20100004338 TOPICAL GEL COMPOSITION COMPRISING AZELAIC ACID  
The present invention discloses a novel azelaic acid topical pharmaceutical gel composition that does not contain lecithin and a process for its preparation.
US20120035356 Hydroxycarboxylic Acids and Salts  
Compositions which inhibit corrosion and alter the physical properties of concrete (admixtures) are prepared from salt mixtures of hydroxycarboxylic acids, carboxylic acids, and nitric acid. The...
US20120245378 USE OF AN ACETIC ACID/WATER SOLVENT MIXTURE FOR THE PREPARATION OF LOW-SULFATE 5-SULFOISOPHTHALIC ACID, MONO-LITHIUM SALT FROM 5-ULFOISOPHTHALIC ACID  
There is disclosed a process for making a mono-lithium salt of 5-sulfoisophthalic acid (LiSIPA) having less than 200 ppm sulfate. The process uses a reaction mixture of acetic acid, water, a...
US20130331450 CLASS II HMG-COA REDUCTASE INHIBITORS AND METHODS OF USE  
Disclosed are compositions and methods for treating bacterial infections.
US20100028512 BIO-BASED POLYETHYLENE TEREPHTHALATE PACKAGING AND METHOD OF MAKING THEREOF  
This invention relates to a method of making a bio-based PET packaging and particularly to a method of producing a bio-based PET from at least one bio-based material comprising: a) forming at...
US20120064790 Ethylene Diphosphinic Acids  
The invention relates to ethylene diphosphinic acids and salts thereof of general formula A-P(O)(OX)—CR1R2—CR3R4—P(O)(OX)-A, in which A, H and/or CR5R6—OH, R1, R2, R3, R4, R5, R6 are the same or...
US20080103334 Process For Synthesis Of Gabapentin  
A process for preparation of gabapentin comprising a step of obtaining 1,1-cyclohexane diacetic acid monoamide from 1,1-cyclohexane diacetic acid anhydride, wherein said reaction is characterized...
US20090143469 SALTS OF NATEGLINIDE  
The present invention relates to salts of organic acid, in particular salt of nateglinide, combined preparations comprising one or more salts of nateglinide and, optionally, one or more additional...
US20090011055 Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism  
The invention relates to plasminogen activator-1 (PAI-1) inhibitor compounds and uses thereof in the treatment of any disease or condition associated with elevated PAI-1. The invention includes,...